达芙通在早期先兆流产中的应用分析  

Application of Duff in treatment for early stage threatened abortion

作　　者：张艳[1] 周晓媚 何佩 钱海芬[1] 喻燕雯[1] 杜易[1] 

机构地区：[1]浙江大学医学院附属第二医院余杭分院妇产科,311100 [2]杭州市妇产科医院药剂科,310006 [3]杭州市妇产科医院妇产科,310006

出　　处：《中华内分泌外科杂志》2017年第2期140-142,共3页Chinese Journal of Endocrine Surgery

摘　　要：目的探讨达芙通在早期先兆流产的临床应用价值。方法对2015年1月至2016年6月在浙江大学医学院附属第二医院余杭分院妇产科收治的早期先兆流产患者中选择1000例，按随机数字表法分为对照组与观察组，各500例，分别给予常规治疗和达芙通治疗。观察2组治疗效果。结果2组临床各项资料差异均无统计学意义（P〉0.05）；均未出现严重不良反应；2组临床症状缓解和消失时间差异均无统计学意义（t=0.334，0.367，均P〉0.05）；观察组的治疗总有效率高于对照组，但2组差异无统计学意义（χ2=0.058，P〉0.05）。结论达芙通治疗早期先兆流产安全、高效，且服用方便，有一定应用价值，值得推广。Objective To explore the application of Duff in treatment for patients with early stage threatened abortion. Method 1000 patients with early stage threatened abortion admitted from Jan. 2015 to Jun. 2016 were selected, and were divided into two groups. All patients were treated by conventional therapy and Duff therapy. Treatment effects of the two groups were observed and compared. Results The differences of clinical characteristics between the two groups had no statistical significance （all P〉0.05）. No serious adverse reactions occurred to either group. There was no significant difference in remission and disappearance time of clinical symptoms between the two groups （t=0.334, 0.367, all P〉0.05）. The total treatment efficiency was higher in the observation group than in the control group, but the differences had no statistical significance （X^2=0.058,P〉0.05）. Conclusion There is a certain application value of Duff treatment for early stage threatened abortion, which is safe, efficient, and convenient, worthy of promotion.

关 键 词：早期先兆流产 达芙通 黄体酮 

分 类 号：R714.21[医药卫生—妇产科学]